Position in HCM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$419,089
-$82,825 QoQ
Shares Held
28,014
-25.6% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 54 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HCM Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $1,135,897,995 across 44 Drug Manufacturers - Specialty & Generic names. HCM ranks #39 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,649,955 | $195,041,180 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
3,315,973 | $171,402,644 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
1,247,447 | $164,338,667 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
4,595,535 | $140,071,906 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
153,372 | $90,946,528 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,893,845 | $57,042,611 | |
| 7 | PRGO |
PERRIGO Co plc
|
4,279,731 | $45,964,310 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
592,013 | $45,525,799 |
All Filings in HCM
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $419,089 | 28,014 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $501,914 | 37,653 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,296,366 | 82,309 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,433,241 | 95,232 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,662,717 | 110,553 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,020,494 | 209,611 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,053,850 | 309,977 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,122,659 | 357,632 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,007,562 | 357,593 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,096,512 | 391,856 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $15,836,630 | 934,866 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,964,356 | 830,363 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,827,446 | 908,406 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $12,858,925 | 870,022 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,199,018 | 361,063 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $639,091 | 50,561 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,073,896 | 109,614 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $3,970,830 | 108,463 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,258,316 | 286,690 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,332,044 | 47,152 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,048,751 | 32,753 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $930,143 | 28,797 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,176,811 | 42,669 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||